Nov 16 Indian manufacturer recalls eyedrops previously cited in FDA warning By Matthew Perrone, Associated Press The action is mainly a formality, since the FDA had already alerted U.S. stores last month to stop selling the over-the-counter drops. Continue reading
Nov 08 FDA approves new version of diabetes drug Mounjaro to be sold for weight loss By JoNel Aleccia, Associated Press The drug has been shown to help dieters lose about a quarter of their body weight, or 60 pounds. It is the latest diabetes drug approved for weight loss, joining Novo Nordisk's Wegovy, a high-dose version of Ozempic. Continue reading
Oct 31 WATCH: Sickle cell gene therapy gets review from FDA advisory committee By Laura Ungar, Associated Press If approved, it would be the first gene therapy on the U.S. market based on CRISPR, the gene editing tool that won its inventors the Nobel Prize in 2020. Continue reading
Oct 30 Eyedrops from CVS, Rite Aid and others carry possible infection risk, FDA says By Associated Press The agency says consumers should stop using the products immediately and avoid purchasing any found in pharmacies and other stores. Continue reading
Oct 28 Watch 6:02 Investigation finds Philips hid safety issues with its CPAP machines for years By Ali Rogin, Andrew Corkery CPAP machines help about 8 million Americans with sleep-related breathing disorders, like sleep apnea, by keeping their airways open while they sleep. But one manufacturer, Philips Respironics, is coming under fire for a critical change it made to millions of… Continue watching
Oct 28 What an FDA advisory panel’s finding that oral phenylephrine is ineffective means for cold and flu meds By Lucas A. Berenbrok, Colleen Culley, Karen Steinmetz Pater, The Conversation The ramp-up to cold and flu season is a bad time for consumers to learn that some of their most trusted go-to products don’t actually work. Continue reading
Sep 29 FDA plans to regulate thousands of lab tests that have long skirted oversight By Matthew Perrone, Associated Press The Food and Drug Administration says it plans to begin regulating laboratory-based medical tests. It's a multibillion-dollar industry that regulators say poses a growing risk to patients. Continue reading
Sep 24 Watch 5:17 How a lack of regulation for tattoo ink puts Americans’ health at risk By John Yang, Andrew Corkery Nearly one in three Americans surveyed this summer said they have at least one tattoo, according to the Pew Research Center. But while tattoo artists are required to have a license in all 50 states and the District of Columbia,… Continue watching
Aug 21 Watch 7:05 Study shows costly weight loss drug may also cut risks of heart attacks By William Brangham, Karina Cuevas The nation’s obesity epidemic is growing. Nearly 42 percent of all American adults are considered obese. Now, new findings about the FDA-approved weight-loss drug Wegovy may lead to even more demand for a medication that can be both life-changing and… Continue watching
Aug 04 FDA approves first postpartum depression pill By Matthew Perrone, Associated Press The Food and Drug Administration approved the drug, called Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. It's taken once a day for 14 days. Continue reading